Research Tracker›Biomarker Atlas›ME/CFS›2-day CPET VO₂ peak (day 2)

2-day CPET VO₂ peak (day 2) in ME/CFS

2-day CPET VO₂ peak (day 2), also described as Cardiopulmonary exercise test, is a functional marker reported as reduced in ME/CFS (ME/CFS, CFS) when patients are compared with the reference group of the cited comparison (Day 1 vs Day 2). Symptom domains tied to this marker in the source include PEM, exercise intolerance. This entry summarises Lim et al. 2020. Group-level associations like this do not translate into an individual diagnostic cut-off.

↓ ReducedFunctional

Summary

Direction in ME/CFS↓ Reduced — lower than in the comparison group
CategoryFunctional
Also described asCardiopulmonary exercise test
Compared againstDay 1 vs Day 2
Associated symptomsPEM, exercise intolerance
Test typeClinical or physiological test
SourceLim et al. 2020 — doi:10.3390/jcm9124040
Condition atlasME/CFS Biomarker Atlas

Trials, interventions and tests

In clinical-trial registrations this marker maps to the outcome term Cardiopulmonary exercise testing (CPET) (25 registered trials use a matching outcome measure).

Clinical trials using 2-day CPET VO₂ peak (day 2) as an outcome

NCT06631287Recruiting
Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID
Outcome measure: Cardiopulmonary exercise testing (CPET)
NCT05858515Withdrawn
REVERSE-Long COVID-19 With Baricitinib Study
Outcome measure: Cardiopulmonary testing
NCT05618574Completed
Nitrite Supplementation in Long COVID Patients
Outcome measure: Walking Efficiency
NCT05530317Terminated
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
Outcome measure: Change in Peak VO2 (ml/kg/min)
NCT05699538Completed
Fatigability in Long COVID-19
Outcome measure: peak VO2
NCT07553897Completed
Tele-exercise Training Program for Long COVID
Outcome measure: Cardiorespiratory Fitness - Peak Oxygen Uptake (VO₂peak)
NCT06161688Active Not Recruiting
Ensitrelvir for Viral Persistence and Inflammation in People Experiencing Long COVID
Outcome measure: Duke Activity Status Index (DASI)
NCT07492953Completed
Using Enhanced External Counterpulsation to Recover Cardiovascular Function for Patient of Chronic Diseases
Outcome measure: Peak oxygen uptake (Peak VO₂)

17 more trials reference this marker.

Interventions studied alongside this marker

Hypothesis-generating links from trial outcome usage and literature co-occurrence. Not treatment recommendations.

Related Functional markers in ME/CFS

Full list: ME/CFS Biomarker Atlas.

Frequently asked questions

Is 2-day CPET VO₂ peak (day 2) high or low in ME/CFS?

Reduced. Studies summarised in the OSMF atlas report lower 2-day CPET VO₂ peak (day 2) in ME/CFS than in the reference group of the cited comparison (Day 1 vs Day 2). Source: Lim et al. 2020.

What symptoms is 2-day CPET VO₂ peak (day 2) associated with in ME/CFS?

The cited literature associates this marker with PEM, exercise intolerance. These are population-level associations and do not mean the marker causes the symptoms.

Which test measures 2-day CPET VO₂ peak (day 2)?

It is measured as a clinical or physiological test. Many of the cited studies used research-grade assays, so clinical availability may vary.

Is one abnormal 2-day CPET VO₂ peak (day 2) result diagnostic of ME/CFS?

No. No single biomarker is diagnostic of ME/CFS. 2-day CPET VO₂ peak (day 2) findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.

Cite this page

Open Source Medicine Foundation. (2026). 2-day CPET VO₂ peak (day 2) in ME/CFS: direction, evidence and what it means. OSMF Research Tracker. Retrieved November 21, 2026, from https://research.opensourcemed.info/biomarkers/me-cfs/2-day-cpet-vo2-peak-day-2.html

Last reviewed: 2026-06-29 · Page generated from me-cfs.json · Browse: ME/CFS atlas · Biomarker Index · All marker pages

Disclaimer: This page is an educational synthesis of published, peer-reviewed research and is not medical advice. Biomarker findings vary across studies with case definitions, comparison groups, timing and assay methods. Direction of change reflects the predominant finding in the cited source and does not establish a diagnostic threshold. Discuss any test result with a qualified clinician.